WaVe Life Sciences Overview
- Founded
- 2010

- Status
- Public
- Employees
- 301

- Stock Symbol
- WVE

- Share Price
- $9.97
- (As of Friday Closing)
WaVe Life Sciences General Information
Description
WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins.
Contact Information
- 733 Concord Avenue
- Cambridge, MA 02138
- United States
WaVe Life Sciences Timeline
WaVe Life Sciences Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$9.97 | $9.77 | $6.61 - $19.98 | $486M | 48.8M | 709K | -$5.01 |
WaVe Life Sciences Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
---|---|---|---|---|
EV | 356,279 | 106,994 | 1,045,266 | 817,642 |
Revenue | 13,038 | 15,983 | 14,414 | 3,893 |
EBITDA | (167,976) | (184,466) | (141,025) | (98,989) |
Net Income | (177,891) | (193,638) | (146,653) | (101,980) |
Total Assets | 310,061 | 284,250 | 295,940 | 181,843 |
Total Debt | 30,165 | 32,547 | 10,403 | 3,454 |
WaVe Life Sciences Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore WaVe Life Sciences‘s full profile, request access.
Request a free trialWaVe Life Sciences Comparisons
Industry
0000000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialWaVe Life Sciences Competitors (42)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Sangamo Therapeutics | Formerly VC-backed | Richmond, CA | 000 | 000.00 | 00000000 | 000.00 |
00000000 000000000 | Formerly VC-backed | Bedford, MA | 000 | 00000 | 000000000 | 00000 |
00000000 000000000 | Private Equity-Backed | San Francisco, CA | 000 | 00000 | 000000&0 | 00000 |
0000000 0000000000 | Venture Capital-Backed | Baltimore, MD | 00 | 000.00 | 00000000000 | 000.00 |
0000 | Formerly VC-backed | Emeryville, CA | 00 | 00000 | 00000000 | 00000 |
WaVe Life Sciences Executive Team (7)
WaVe Life Sciences Board Members (9)
Name | Representing | Role | Since |
---|---|---|---|
Adrian Rawcliffe | Self | Board Member | 000 0000 |
Christian Henry | Self | Chairman & Board Member | 000 0000 |
Gregory Verdine Ph.D | WaVe Life Sciences | Board Member & Founder | 000 0000 |
Ken Takanashi | Self | Board Member | 000 0000 |
Koji Miura | Self | Board Member | 000 0000 |
WaVe Life Sciences Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialWaVe Life Sciences Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore WaVe Life Sciences‘s full profile, request access.
Request a free trial